FORT WORTH, Texas, May 02, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug ...
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Statements made in this press release regarding matters that are not historical facts are “forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (TFF), an early-stage biopharmaceutical company focused on developing and commercializing new inhalation drug products for the treatment of ...
The candidate MCMs delivered by Leidos to TFF Pharmaceuticals have been successfully formulated utilizing the Company’s proprietary Thin Film Freezing technology platform. Formulated materials have ...
TFF Pharmaceuticals and Catalent will collaborate to develop TFF's platform for manufacturing dry powder particles. TFF Pharmaceuticals, a clinical-stage biopharmaceutical company, and Catalent ...
Newly published data in the Journal of Drug Delivery Science and Technology demonstrate more uniform drug distribution in the lung compared with other technologies FORT WORTH, Texas, Sept. 26, 2024 ...
TFF Group (EPA:TFF) is a small-cap stock with a market capitalization of €797.8m. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results